Cargando…
Functional MRI technologies in the study of medication treatment effect on Alzheimer's disease
Alzheimer's disease (AD) is the most common cause of late‐life dementia. Characterized by progressive neurodegeneration, the disease is expressed as gradual memory loss together with decline in cognitive abilities and other brain functions. Despite extensive research over the past decade, the c...
Autores principales: | Guo, Hui, Grajauskas, Lukas, Habash, Baraa, D'Arcy, Ryan CN, Song, Xiaowei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6880690/ https://www.ncbi.nlm.nih.gov/pubmed/31942484 http://dx.doi.org/10.1002/agm2.12017 |
Ejemplares similares
-
Toward MRI‐based whole‐brain health assessment: The brain atrophy and lesion index (BALI)
por: Grajauskas, Lukas A., et al.
Publicado: (2018) -
MRI assessment of whole-brain structural changes in aging
por: Guo, Hui, et al.
Publicado: (2017) -
White Matter fMRI Activation Cannot Be Treated as a Nuisance Regressor: Overcoming a Historical Blind Spot
por: Grajauskas, Lukas A., et al.
Publicado: (2019) -
Imaging functional neuroplasticity in human white matter tracts
por: Frizzell, Tory O., et al.
Publicado: (2021) -
White Matter Neuroplasticity: Motor Learning Activates the Internal Capsule and Reduces Hemodynamic Response Variability
por: Frizzell, Tory O., et al.
Publicado: (2020)